Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:55
Sanofi Taps Adviser for OTC Spinoff as Buyout Firms Circle
Sanofi is working with an adviser to start preparations for a planned separation of its consumer health division,
2023-11-16 16:22
Sanofi Probed for Market Manipulation by French Authorities
French financial prosecutors are investigating Sanofi for alleged market manipulation. The preliminary probe opened in March involves alleged
2023-11-08 00:54
Sanofi Lifts Guidance on Dupixent, Covid Vaccine Sales
Sanofi raised its forecast for the year as the French drugmaker gains new patients for blockbuster drug Dupixent
2023-07-28 13:52
LVMH to Sponsor Paris Olympics in a First for Luxury Group
LVMH agreed to become a premium sponsor of the 2024 Summer Olympics in Paris in the first deal
2023-07-25 14:58
Sanofi Cuts Zantac Risk With Arbitration Win Over Boehringer
Sanofi defeated Boehringer Ingelheim GmbH in an arbitration proceeding over legal responsibilities tied to controversial heartburn medicine Zantac.
2023-06-20 15:22
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:15